ENTITY

Neurocrine Biosciences (NBIX US)

37
Analysis
Health Care • United States
Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, Alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
more
•07 Aug 2026 22:56

Primer: Neurocrine Biosciences (NBIX US) - Aug 2026

Neurocrine is successfully transitioning from a single-product company to a diversified biopharmaceutical leader, driven by the strong...

Logo
95 Views
Share
x